Behind ADVITOS GmbH is a dynamic and international team that together develops innovations and thus contributes to new medical solutions.
ADVITOS GmbH currently employs 55 permanent staff members covering all areas of a certified medical technology company – from research, development and production, through regulatory and clinical matters to application advice, service, marketing and sales.
Dr. Claus Jessen studied Mechanical Engineering in Darmstadt and Aachen, where he subsequently completed his doctorate. He joined Fresenius as a Project Engineer in the development of disposables and the associated automation technology. When Fresenius Medical Care was founded, he became Head of Development there and later Plant Manager at the production facility for dialysis machines in Schweinfurt.
Dr. Jessen then started as Plant Manager for the production of pneumatic drives for Festo in Saarland. His professional development at Festo led to responsibility for global production and then to the Board of Directors for supply chain and the CEO of the Board of Directors.
Dr. Jessen accompanies ADVITOS since its foundation and took over as Head of Research & Development at the beginning of 2021. He is the CEO of ADVITOS GmbH since June 2022.
Advisory board (Chairman)
Managing Director MedConsult GmbH; Former Chairman Teraklin; Former board member Schwarz Pharma; Former member of the Management Board of Fresenius Medical Care AG (FMC); Former member of the Executive Board, Siemens-Elema
Former CFO Kion Group GmbH; CEO Jelmoli AG; CFO Arcandor AG; CFO Messer Group and CFO Fresenius Kabi AG
Senior VP Regulatory, Legal and Quality MAXIS LLC; former Member of the Executive Board Novalung GmbH
Investment Director Crédit Mutuel Innovation
Founder ADVITOS GmbH, inventor of the ADVOS therapy